Asahikawa Medical University, Kyokui, or AMU, is a national university and medical school in Asahikawa, Hokkaido, Japan. Established in 1973, the university has one faculty, Faculty of Medicine, consisting of Department of Medicine and Department of Nursing.

During the past decade, Asahikawa Medical University Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 14 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 12 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asahikawa Medical University Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asahikawa Medical University Hospital" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Maruishi Pharmaceutical" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Asahikawa Medical University Hospital" are "Macular Edema" (3 trials), "Psoriasis" (3 trials), "Colorectal Cancer" (2 trials), "Crohn's Disease" (2 trials) and "Diabetic Macular Edema" (2 trials). Many other conditions were trialed in "Asahikawa Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Asahikawa Medical University Hospital" are "Drug" (32 trials), "Procedure" (5 trials), "Device" (4 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials) and "Guselkumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Asahikawa Medical University Hospital" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Asahikawa Medical University Hospital". undefined are not yet recruiting, 7 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Asahikawa Medical University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Asahikawa Medical University Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".